Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px
Organisation › Details

Jeito Capital S.A.S.

Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients' access in Europe & the United States. Jeito Capital has €534 million under management. Jeito Capital is based in Paris with a presence in Europe and the United States. *


Period Start 2018-06-25 established
  Group Jeito Capital (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Tordjman, Rafaèle (Jeito Capital 201806– President + Founder before Sofinnova Partners 2001–2017)
  Person 2 Clancy, Annette (Enyo Pharma 201806 Chair of Board of Directors)
Region Region Paris
  Country France
  Street 33 rue La Fayette
  City 75009 Paris
    Address record changed: 2021-07-10
Basic data Employees n. a.
  Currency EUR
  Annual sales 534,000,000 (capital under management (2021) 2021-11-29)
    * Document for »About Section«: Quell Therapeutics Ltd.. (11/29/21). "Press Release: Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform". London & Boston,
Record changed: 2023-09-11


Picture EBD Group Biotech Showcase 2024 San Francisco 650x200px

More documents for Jeito Capital (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top